Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications: Out-of-specification test results.
| Brand name | OSELTAMIVIR PHOSPHATE |
| Generic name | OSELTAMIVIR PHOSPHATE |
| Active ingredient(s) | OSELTAMIVIR PHOSPHATE |
| Distributed by / for | Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 |
| NDC | 69238-1273-6 |
| Full product label | Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6 |
| Recalling firm | Amneal Pharmaceuticals of New York, LLC |
| Distribution | Nationwide in the USA |
| Quantity | 46,037 Bottles |
| Recall initiated | 2024-02-13 |
| Report date | 2024-02-28 |
| Recall completed | 2025-02-14 |
| Recall number | D-0327-2024 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Brookhaven NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗